BioNTech CEO Uğur Şahin disposes of $7.84 million in common shares
BNTX•CEO discloses share sales
BioNTech CEO Uğur Şahin disclosed sales of 79,000 ordinary shares on Sept. 21-22, cutting his direct stake to 410,209 shares.
Transactions were priced at USD 97.81 and USD 100.72 per share, per the filing.
The filing also listed 39,218,111 ordinary shares held indirectly.




